1. Home
  2. TLSI vs RDNW Comparison

TLSI vs RDNW Comparison

Compare TLSI & RDNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TLSI
  • RDNW
  • Stock Information
  • Founded
  • TLSI 2010
  • RDNW 2013
  • Country
  • TLSI United States
  • RDNW United States
  • Employees
  • TLSI N/A
  • RDNW N/A
  • Industry
  • TLSI Medical Specialities
  • RDNW EDP Services
  • Sector
  • TLSI Health Care
  • RDNW Technology
  • Exchange
  • TLSI Nasdaq
  • RDNW Nasdaq
  • Market Cap
  • TLSI 150.0M
  • RDNW 147.3M
  • IPO Year
  • TLSI N/A
  • RDNW N/A
  • Fundamental
  • Price
  • TLSI $5.05
  • RDNW $3.99
  • Analyst Decision
  • TLSI Strong Buy
  • RDNW
  • Analyst Count
  • TLSI 5
  • RDNW 0
  • Target Price
  • TLSI $10.90
  • RDNW N/A
  • AVG Volume (30 Days)
  • TLSI 112.5K
  • RDNW 2.1M
  • Earning Date
  • TLSI 08-12-2025
  • RDNW 08-11-2025
  • Dividend Yield
  • TLSI N/A
  • RDNW N/A
  • EPS Growth
  • TLSI N/A
  • RDNW N/A
  • EPS
  • TLSI N/A
  • RDNW N/A
  • Revenue
  • TLSI $35,990,000.00
  • RDNW $1,109,200,000.00
  • Revenue This Year
  • TLSI $56.79
  • RDNW N/A
  • Revenue Next Year
  • TLSI $54.15
  • RDNW $7.73
  • P/E Ratio
  • TLSI N/A
  • RDNW N/A
  • Revenue Growth
  • TLSI 45.50
  • RDNW N/A
  • 52 Week Low
  • TLSI $3.42
  • RDNW $1.46
  • 52 Week High
  • TLSI $5.88
  • RDNW $7.06
  • Technical
  • Relative Strength Index (RSI)
  • TLSI 55.11
  • RDNW N/A
  • Support Level
  • TLSI $4.80
  • RDNW N/A
  • Resistance Level
  • TLSI $5.24
  • RDNW N/A
  • Average True Range (ATR)
  • TLSI 0.35
  • RDNW 0.00
  • MACD
  • TLSI 0.02
  • RDNW 0.00
  • Stochastic Oscillator
  • TLSI 72.18
  • RDNW 0.00

About TLSI TriSalus Life Sciences Inc.

TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.

About RDNW RideNow Group Inc. Class B Common Stock

RideNow Group Inc is a USA-based online retailer that allows consumers and dealers both to Buy-Sell-Trade-Finance pre-owned motorcycles in an efficient, fast, transparent, and engaging experience.

Share on Social Networks: